ID   MAST2_HUMAN             Reviewed;        1798 AA.
AC   Q6P0Q8; O94899; Q5VT07; Q5VT08; Q7LGC4; Q8NDG1; Q96B94; Q9BYE8;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2005, sequence version 2.
DT   05-OCT-2010, entry version 72.
DE   RecName: Full=Microtubule-associated serine/threonine-protein kinase 2;
DE            EC=2.7.11.1;
GN   Name=MAST2; Synonyms=KIAA0807, MAST205;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS GLU-388; MET-659 AND
RP   GLY-1551, SUBCELLULAR LOCATION, AND INTERACTION WITH CDHR2.
RC   TISSUE=Brain;
RX   MEDLINE=22112621; PubMed=12117771; DOI=10.1093/carcin/23.7.1139;
RA   Okazaki N., Takahashi N., Kojima S., Masuho Y., Koga H.;
RT   "Protocadherin LKC, a new candidate for a tumor suppressor of colon
RT   and liver cancers, its association with contact inhibition of cell
RT   proliferation.";
RL   Carcinogenesis 23:1139-1148(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORM 1).
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 281-1798 (ISOFORM 2), AND VARIANT
RP   MET-659.
RC   TISSUE=Lymph, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 470-1797 (ISOFORM 1), AND
RP   VARIANTS MET-659 AND GLY-1551.
RC   TISSUE=Brain;
RX   MEDLINE=99087487; PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
RN   [5]
RP   SEQUENCE REVISION TO C-TERMINUS.
RA   Ohara O., Suyama M., Nagase T., Ishikawa K., Kikuno R.;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 833-1797 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=8902215;
RA   Walden P.D., Millette C.F.;
RT   "Increased activity associated with the MAST205 protein kinase complex
RT   during mammalian spermiogenesis.";
RL   Biol. Reprod. 55:1039-1044(1996).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1503 AND THR-1508, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74 AND SER-900, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74 AND SER-148, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-69; GLU-275; GLU-388; ALA-655;
RP   MET-659; LEU-991; ARG-1197; GLU-1221; LEU-1246; MET-1304; THR-1463;
RP   ALA-1468; GLY-1551; ARG-1673 AND GLU-1703.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Appears to link the dystrophin/utrophin network with
CC       microtubule filaments via the syntrophins. Phosphorylation of DMD
CC       or UTRN may modulate their affinities for associated proteins.
CC       Functions in a multi-protein complex in spermatid maturation.
CC       Regulates lipopolysaccharide-induced IL-12 synthesis in
CC       macrophages by forming a complex with TRAF6, resulting in the
CC       inhibition of TRAF6 NF-kappa-B activation (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium (By similarity).
CC   -!- SUBUNIT: Interacts with CDHR2.
CC   -!- INTERACTION:
CC       Q92616:GCN1L1; NbExp=1; IntAct=EBI-493777, EBI-356221;
CC       Q9BYE9:PCDH24; NbExp=3; IntAct=EBI-493777, EBI-493793;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cell membrane;
CC       Peripheral membrane protein; Cytoplasmic side (Potential).
CC       Note=Recruited to the sub-membranous area on interaction with
CC       CDHR2.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6P0Q8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6P0Q8-2; Sequence=VSP_051698, VSP_051699, VSP_051700;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Abundant in the testis.
CC   -!- PTM: Phosphorylated and ubiquitinated. N-terminal ubiquitination
CC       leads to degradation of MAST2 by proteasome-mediated proteolysis.
CC       N-terminal phosphorylation appears to be a prerequisite for
CC       ubiquitination (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 PDZ (DHR) domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH15816.2; Type=Erroneous initiation;
CC       Sequence=AAH15816.2; Type=Frameshift; Positions=1114, 1387;
CC       Sequence=BAB40778.1; Type=Frameshift; Positions=1688;
CC       Sequence=CAH73245.1; Type=Erroneous gene model prediction;
CC       Sequence=CAI16563.1; Type=Erroneous gene model prediction;
CC       Sequence=CAI21706.1; Type=Erroneous gene model prediction;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB047005; BAB40778.1; ALT_FRAME; mRNA.
DR   EMBL; AL645480; CAH73244.1; -; Genomic_DNA.
DR   EMBL; AL358075; CAH73244.1; JOINED; Genomic_DNA.
DR   EMBL; AL603882; CAH73244.1; JOINED; Genomic_DNA.
DR   EMBL; AL603888; CAH73244.1; JOINED; Genomic_DNA.
DR   EMBL; AL645480; CAH73245.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL358075; CAH73245.1; JOINED; Genomic_DNA.
DR   EMBL; AL603888; CAH73245.1; JOINED; Genomic_DNA.
DR   EMBL; AL603882; CAI16217.1; -; Genomic_DNA.
DR   EMBL; AL358075; CAI16217.1; JOINED; Genomic_DNA.
DR   EMBL; AL603888; CAI16217.1; JOINED; Genomic_DNA.
DR   EMBL; AL645480; CAI16217.1; JOINED; Genomic_DNA.
DR   EMBL; AL603888; CAI16562.1; -; Genomic_DNA.
DR   EMBL; AL358075; CAI16562.1; JOINED; Genomic_DNA.
DR   EMBL; AL603882; CAI16562.1; JOINED; Genomic_DNA.
DR   EMBL; AL645480; CAI16562.1; JOINED; Genomic_DNA.
DR   EMBL; AL603888; CAI16563.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL358075; CAI16563.1; JOINED; Genomic_DNA.
DR   EMBL; AL645480; CAI16563.1; JOINED; Genomic_DNA.
DR   EMBL; AL358075; CAI21705.1; -; Genomic_DNA.
DR   EMBL; AL603882; CAI21705.1; JOINED; Genomic_DNA.
DR   EMBL; AL603888; CAI21705.1; JOINED; Genomic_DNA.
DR   EMBL; AL645480; CAI21705.1; JOINED; Genomic_DNA.
DR   EMBL; AL358075; CAI21706.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL603888; CAI21706.1; JOINED; Genomic_DNA.
DR   EMBL; AL645480; CAI21706.1; JOINED; Genomic_DNA.
DR   EMBL; BC015816; AAH15816.2; ALT_INIT; mRNA.
DR   EMBL; BC065499; AAH65499.1; -; mRNA.
DR   EMBL; AB018350; BAA34527.2; -; mRNA.
DR   EMBL; AL833919; CAD38775.1; -; mRNA.
DR   IPI; IPI00480046; -.
DR   IPI; IPI00514071; -.
DR   RefSeq; NP_055927.2; -.
DR   UniGene; Hs.319481; -.
DR   ProteinModelPortal; Q6P0Q8; -.
DR   SMR; Q6P0Q8; 325-425, 506-842, 1105-1201.
DR   IntAct; Q6P0Q8; 7.
DR   MINT; MINT-1892333; -.
DR   STRING; Q6P0Q8; -.
DR   PhosphoSite; Q6P0Q8; -.
DR   PRIDE; Q6P0Q8; -.
DR   Ensembl; ENST00000361297; ENSP00000354671; ENSG00000086015.
DR   GeneID; 23139; -.
DR   KEGG; hsa:23139; -.
DR   UCSC; uc001cov.1; human.
DR   CTD; 23139; -.
DR   GeneCards; GC01P046252; -.
DR   H-InvDB; HIX0000540; -.
DR   HGNC; HGNC:19035; MAST2.
DR   PharmGKB; PA134954073; -.
DR   HOVERGEN; HBG052414; -.
DR   InParanoid; Q6P0Q8; -.
DR   OMA; MPRFAIS; -.
DR   OrthoDB; EOG97WR6T; -.
DR   PhylomeDB; Q6P0Q8; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 44410; -.
DR   ArrayExpress; Q6P0Q8; -.
DR   Bgee; Q6P0Q8; -.
DR   CleanEx; HS_MAST2; -.
DR   Genevestigator; Q6P0Q8; -.
DR   GermOnline; ENSG00000086015; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0019902; F:phosphatase binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; ISS:UniProtKB.
DR   GO; GO:0045075; P:regulation of interleukin-12 biosynthetic p...; ISS:UniProtKB.
DR   GO; GO:0048515; P:spermatid differentiation; ISS:UniProtKB.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR015022; DUF1908.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR001478; PDZ/DHR/GLGF.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF08926; DUF1908; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50156; PDZ; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Kinase; Magnesium; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN         1   1798       Microtubule-associated serine/threonine-
FT                                protein kinase 2.
FT                                /FTId=PRO_0000086312.
FT   DOMAIN      512    785       Protein kinase.
FT   DOMAIN      786    854       AGC-kinase C-terminal.
FT   DOMAIN     1104   1192       PDZ.
FT   NP_BIND     518    526       ATP (By similarity).
FT   ACT_SITE    635    635       Proton acceptor (By similarity).
FT   BINDING     541    541       ATP (By similarity).
FT   MOD_RES      74     74       Phosphoserine.
FT   MOD_RES     148    148       Phosphoserine.
FT   MOD_RES     151    151       Phosphoserine (By similarity).
FT   MOD_RES     900    900       Phosphoserine.
FT   MOD_RES    1503   1503       Phosphoserine.
FT   MOD_RES    1508   1508       Phosphothreonine.
FT   VAR_SEQ     327    396       Missing (in isoform 2).
FT                                /FTId=VSP_051698.
FT   VAR_SEQ    1091   1113       Missing (in isoform 2).
FT                                /FTId=VSP_051699.
FT   VAR_SEQ    1290   1386       Missing (in isoform 2).
FT                                /FTId=VSP_051700.
FT   VARIANT      69     69       L -> F (in dbSNP:rs55914403).
FT                                /FTId=VAR_040771.
FT   VARIANT     275    275       K -> E (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040772.
FT   VARIANT     388    388       D -> E (in dbSNP:rs11211247).
FT                                /FTId=VAR_040773.
FT   VARIANT     655    655       G -> A (in a breast mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040774.
FT   VARIANT     659    659       I -> M (in dbSNP:rs1707336).
FT                                /FTId=VAR_040775.
FT   VARIANT     991    991       R -> L (in dbSNP:rs56114653).
FT                                /FTId=VAR_040776.
FT   VARIANT    1197   1197       K -> R (in dbSNP:rs1052607).
FT                                /FTId=VAR_040777.
FT   VARIANT    1221   1221       D -> E (in dbSNP:rs56060730).
FT                                /FTId=VAR_040778.
FT   VARIANT    1246   1246       R -> L (in dbSNP:rs56309943).
FT                                /FTId=VAR_040779.
FT   VARIANT    1304   1304       V -> M (in dbSNP:rs33931638).
FT                                /FTId=VAR_040780.
FT   VARIANT    1463   1463       A -> T (in dbSNP:rs3737738).
FT                                /FTId=VAR_040781.
FT   VARIANT    1468   1468       G -> A (in dbSNP:rs3737737).
FT                                /FTId=VAR_040782.
FT   VARIANT    1551   1551       D -> G (in dbSNP:rs1052610).
FT                                /FTId=VAR_040783.
FT   VARIANT    1608   1608       T -> I (in dbSNP:rs35474583).
FT                                /FTId=VAR_051645.
FT   VARIANT    1673   1673       K -> R (in dbSNP:rs34070850).
FT                                /FTId=VAR_040784.
FT   VARIANT    1703   1703       G -> E.
FT                                /FTId=VAR_040785.
FT   CONFLICT   1225   1225       Missing (in Ref. 3; AAH65499).
SQ   SEQUENCE   1798 AA;  196436 MW;  DF5C92078A3451AF CRC64;
     MKRSRCRDRP QPPPPDRRED GVQRAAELSQ SLPPRRRAPP GRQRLEERTG PAGPEGKEQD
     VVTGVSPLLF RKLSNPDIFS STGKVKLQRQ LSQDDCKLWR GNLASSLSGK QLLPLSSSVH
     SSVGQVTWQS SGEASNLVRM RNQSLGQSAP SLTAGLKELS LPRRGSFCRT SNRKSLIVTS
     STSPTLPRPH SPLHGHTGNS PLDSPRNFSP NAPAHFSFVP ARRTDGRRWS LASLPSSGYG
     TNTPSSTVSS SCSSQEKLHQ LPFQPTADEL HFLTKHFSTE SVPDEEGRQS PAMRPRSRSL
     SPGRSPVSFD SEIIMMNHVY KERFPKATAQ MEERLAEFIS SNTPDSVLPL ADGALSFIHH
     QVIEMARDCL DKSRSGLITS QYFYELQDNL EKLLQDAHER SESSEVAFVM QLVKKLMIII
     ARPARLLECL EFDPEEFYHL LEAAEGHAKE GQGIKCDIPR YIVSQLGLTR DPLEEMAQLS
     SCDSPDTPET DDSIEGHGAS LPSKKTPSEE DFETIKLISN GAYGAVFLVR HKSTRQRFAM
     KKINKQNLIL RNQIQQAFVE RDILTFAENP FVVSMFCSFD TKRHLCMVME YVEGGDCATL
     LKNIGALPVD MVRLYFAETV LALEYLHNYG IVHRDLKPDN LLITSMGHIK LTDFGLSKIG
     LMSLTTNLYE GHIEKDAREF LDKQVCGTPE YIAPEVILRQ GYGKPVDWWA MGIILYEFLV
     GCVPFFGDTP EELFGQVISD EIVWPEGDEA LPPDAQDLTS KLLHQNPLER LGTGSAYEVK
     QHPFFTGLDW TGLLRQKAEF IPQLESEDDT SYFDTRSERY HHMDSEDEEE VSEDGCLEIR
     QFSSCSPRFN KVYSSMERLS LLEERRTPPP TKRSLSEEKE DHSDGLAGLK GRDRSWVIGS
     PEILRKRLSV SESSHTESDS SPPMTVRRRC SGLLDAPRFP EGPEEASSTL RRQPQEGIWV
     LTPPSGEGVS GPVTEHSGEQ RPKLDEEAVG RSSGSSPAME TRGRGTSQLA EGATAKAISD
     LAVRRARHRL LSGDSTEKRT ARPVNKVIKS ASATALSLLI PSEHHTCSPL ASPMSPHSQS
     SNPSSRDSSP SRDFLPALGS MRPPIIIHRA GKKYGFTLRA IRVYMGDSDV YTVHHMVWHV
     EDGGPASEAG LRQGDLITHV NGEPVHGLVH TEVVELILKS GNKVAISTTP LENTSIKVGP
     ARKGSYKAKM ARRSKRSRGK DGQESRKRSS LFRKITKQAS LLHTSRSLSS LNRSLSSGES
     GPGSPTHSHS LSPRSPTQGY RVTPDAVHSV GGNSSQSSSP SSSVPSSPAG SGHTRPSSLH
     GLAPKLQRQY RSPRRKSAGS IPLSPLAHTP SPPPPTASPQ RSPSPLSGHV AQAFPTKLHL
     SPPLGRQLSR PKSAEPPRSP LLKRVQSAEK LAAALAASEK KLATSRKHSL DLPHSELKKE
     LPPREVSPLE VVGARSVLSG KGALPGKGVL QPAPSRALGT LRQDRAERRE SLQKQEAIRE
     VDSSEDDTEE GPENSQGAQE LSLAPHPEVS QSVAPKGAGE SGEEDPFPSR DPRSLGPMVP
     SLLTGITLGP PRMESPSGPH RRLGSPQAIE EAASSSSAGP NLGQSGATDP IPPEGCWKAQ
     HLHTQALTAL SPSTSGLTPT SSCSPPSSTS GKLSMWSWKS LIEGPDRASP SRKATMAGGL
     ANLQDLENTT PAQPKNLSPR EQGKTQPPSA PRLAHPSYED PSQGWLWESE CAQAVKEDPA
     LSITQVPDAS GDRRQDVPCR GCPLTQKSEP SLRRGQEPGG HQKHRDLALV PDELLKQT
//
